SELICK HAROLD E 4
4 · Protagonist Therapeutics, Inc · Filed Apr 30, 2025
Insider Transaction Report
Form 4
SELICK HAROLD E
Director
Transactions
- Exercise/Conversion
Common Stock
2025-04-28$1.16/sh+10,725$12,441→ 43,851 total - Exercise/Conversion
Stock Option (right to buy)
2025-04-28−10,725→ 0 totalExercise: $1.16Exp: 2025-10-28→ Common Stock (10,725 underlying)
Footnotes (1)
- [F1]These stock options are fully vested.